Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed Streptococcal preparation Motoo SaitoOsamu IchimuraNakao Ishida Original Articles Pages: 161 - 168
Site-related differences in the localization of the monoclonal antibody OX7 in SL2 and SL1 lymphomas Howard SandsPeter L. JonesBrian M. Gallagher Original Articles Pages: 169 - 175
Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 Target cell lines Rigmor AustgulenOdd Kildahl-AndersenTerje Espevik Original Articles Pages: 176 - 180
The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites Masuo HosokawaTakanori MizukoshiHiroshi Kobayashi Original Articles Pages: 181 - 185
Growth factors for human tumor clonogenic cells elaborated by macrophages isolated from human malignant effusions Anne W. HamburgerChristine P. White Original Articles Pages: 186 - 190
A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state Saburo SoneTeruhiro UtsugiMitsumasa Ogawara Original Articles Pages: 191 - 196
Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells Robert J. NatukJacquelyn A. ByrneJ. A. Holowczak Original Articles Pages: 197 - 203
Immunogenicity of viable tumor cells Yasuhiro SuzukiKazufumi SuzukiHiroshi Kobayashi Original Articles Pages: 204 - 210
Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon Edward D. BallKim E. NicholsMichael W. Fanger Original Articles Pages: 211 - 216
Effects of the interferon-inducer ABPP on colon cancer in rats; importance of tumor load and tumor site Alexander M. M. EggermontRichard L. MarquetJohannes Jeekel Original Articles Pages: 217 - 220
Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma Peter HerseyAnne EdwardsMalcolm MacDonald Original Articles Pages: 221 - 231
Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions F. IndiveriI. PierriS. Ferrone Original Articles Pages: 232 - 235